Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice

Fig. 2

The expressions of fibrosis and inflammation markers were elevated in the NA/STZ/Suc mice, and were normalized by canagliflozin treatment. a AZAN staining of kidney sections. Scale bars: 50 μm. b Relative mRNA levels of fibrotic markers in the kidneys were investigated. (n = 5). c Relative mRNA levels of inflammatory cytokines in the kidneys. (n = 5) *,#P < 0.05, **,##P < 0.01, ***P < 0.001

Back to article page